All News

The study examined the cost to Medicare when patients with end-stage renal disease switched from their employer-based health insurance to Medicare between 2007 and 2017 before the end of the 30-month coordination period.

A new study suggests that 3-feet social distancing is sufficient for in-person instruction in public schools; Amazon announces it will offer its Amazon Care telemedicine program to private employers nationwide; ACIST Kodama Intravascular Ultrasound Catheter recalled.

Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension had similar incidence of COVID-19, but the impact on clinical operations at the centers that treat these patients was substantial.

Patients with multiple sclerosis have high rates of urinary and kidney infections, inpatient hospitalizations, and outpatient hospital claims, according to recent results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting.

Patients with obstructive sleep apnea (OSA) and history of cardiovascular disease treated with continuous positive airway pressure (CPAP) therapy were shown to report 20% higher levels of moderate physical activity compared with non-CPAP users, with these patients also more likely to exercise at levels meeting clinical recommendations.

A panel of experts provided consumer insights into value-based insurance design (VBID) and how the COVID-19 pandemic may have changed consumer behaviors in a way that VBID may be able to address as the country emerges from the pandemic.

Responses from a study of in-person focus groups show that not only do patients report adverse effects on quality of life, physical well-being, and mental health but that their caregivers do as well.

While an association was found between dementia and the most common form of lupus, links to other autoimmune diseases—rheumatic arthritis, Sjögren’s syndrome, and Behcet’s disease—were not found.

Results of a scoping review of 19 studies indicate estrogen likely plays a key role in migraine pathogenesis but affects patients in different ways depending on past medical history, age, and use of hormonal therapy.

The FDA issues updated guidance on the emergency use authorization (EUA) process for COVID-19 screening tools; Eli Lilly releases patient-reported outcome results for Verzenio (abemaciclib) in breast cancer; COVID-19 vaccines possibly improve long-haul symptoms among patients.

A value-based care team approach can be utilized to adequately treat patients’ medical problems, particularly by addressing the social, economic, and environmental challenges they’re facing in their everyday lives.

A desire to remove barriers to high-value care and provide services that would improve health and quality of life drove early adopters of value-based insurance design (VBID).

A novel skin test was shown to detect metabolites that could predict the development of Parkinson disease, as well as delineate changes in lipid processing and mitochondria that can be leveraged to better understand how the disease develops.

The safety and effectiveness of the long-acting agent is backed by data from trials of the drug among treatment-experienced individuals living with HIV-1 whose viral load is on the rise due to other regimens failing. Investigation continues among these patients, as well as treatment-naive patients.

Fear of exposure to COVID-19 is associated with patients missing ophthalmic care appointments, suggesting the potential importance of conveying practices’ infection-control measures, according to results of a non-validated survey.

Evidence points to the origins of COVID-19 variants; officials urge former President Trump to encourage supporters to receive a COVID-19 vaccine; Purdue Pharma releases a bankruptcy plan.

As part of the study, investigators looked into the long-term risk of cancer as affected by immediate initiation of antiretroviral therapy (ART).

In a review published in Eye and Brain, researchers outlined the link between dry eye and migraine, their possible shared pathophysiology, and therapies targeting similar pathophysiological mechanisms.

Study findings shed a light on the role of minimal residual disease (MRD) status and type of postremission therapy in the prognosis of patients with intermediate-risk acute myeloid leukemia (AML) who do not have FLT3-ITD, NPM1, and biallelic CEBPA mutations.

Between 1999 and 2018, Black adults living in rural regions of the United States experienced high mortality rates due to diabetes, high blood pressure, heart disease, and stroke compared with White adults, according to new research published in the Journal of the American College of Cardiology.

Field loss may not be the only visual deficit resulting from macular damage while resulting functional losses may impair facial recognition, according to new research published in JAMA Ophthalmology.

AstraZeneca refutes reports linking its COVID-19 vaccine with recent deaths in Europe from blood clots; Anthony Fauci, MD, cautions against lifting US restrictions too soon amid case spikes in Europe; the White House is set to reveal a $1.5 billion public relations campaign to boost vaccine confidence and uptake nationwide.

Anita Makkenchery, MD, MPH, and Brandy Farrar, PhD, discuss how community health workers can address COVID-19 vaccine hesitancy.

A panel of policy experts, including employees of the previous 2 administrations and a former lobbyist for health plans, discusses achievements of value-based insurance design and how to take the concept to the next level.

With a marked increase in virtual care use amid the COVID-19 pandemic, several strategies can continue to evolve its effectiveness and adoption. This includes addressing disparities in usage among older populations and underserved communities, as well as improving home monitoring and interoperability.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Results of a survey depicting the ways that spinal muscular atrophy (SMA) affects the lives of adolescents and young adults revealed areas of support that need to be addressed to ensure that patients are able to live their best possible lives.

According to the researchers, the findings are paving the way toward precision medicine and may have broader use in tracking treatment response in adult-onset motor neuropathy in the future.